Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital

Frontiers in Immunology(2023)10.3389/fimmu.2023.1123497Source: DataRank Database

Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.19)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Jaime Alfonso M. Aherrera,Sheriah Laine M. de Paz‐Silava ORCID,Alric V. Mondragon ORCID,Anna Flor G. Malundo ORCID,Joanne Jennifer E. Tan ORCID

Live enrichment

PubMed:36926338 PMC:PMC10011458 OpenAlex:https://openalex.org/W4323320135

Philippine Council for Health Research and Development

FWCI

1.19

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1123497/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1123497/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1123497/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1123497/full

journalhttps://doi.org/10.3389/fimmu.2023.1123497

Fields of Study

COVID-19 Clinical Research StudiesInflammatory Biomarkers in Disease PrognosisSARS-CoV-2 and COVID-19 ResearchMedicineHumansCOVID-19Interleukin-18Interleukin-6Tertiary Care CentersPandemicsChemokine CXCL10HypoalbuminemiaPhilippinesBiomarkersCytokinesDisease ProgressionLymphopenia

MeSH Terms

COVID-19HumansLymphopeniaPhilippinesBiomarkersInterleukin-6CytokinesDisease ProgressionInterleukin-18HypoalbuminemiaChemokine CXCL10PandemicsTertiary Care Centers

Keywords

MedicineDiseaseCoronavirus disease 2019 (COVID-19)Immune system2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineIntensive care medicineImmunologyInfectious disease (medical specialty)PathologyOutbreakCytokinesMortalityBiomarkersDisease ProgressionFilipinoCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being